Ototoxicity of cyclodextrin derivatives
There are two possible mechanisms behind the ototoxicity of 2-hydroxypropyl-β-cyclodextrin (HPBCD) treatment. One is : the possible interaction of HPBCD
Category: Drug delivery
CD‐sACE2 complexes against Covid-19
Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .
Book: Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents provides sound data on the utility of
Veklury (remdesivir) becomes the first approved drug for the treatment of COVID-19 in the European Union
On the 3rd of July we arrived to another milestone in the fight against the novel coronavirus infection. Eurpean Comission
Repurpusing Famotidine against COVID-19: a Hope or a Hype?
Clinicians and scientists have been studying a number of old existing drugs with the hope of finding therapies they can
Trans sodium crocetinate/cyclodextrin to increase diffusion of oxygen
Diffusion Pharmaceuticals Inc., a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to
Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
Crocetin (CRT) has shown various neuroprotective effects such as antioxidant activities and the inhibition of amyloid β fibril formation, and
Summary of currently available drugs which can be potentially used for treatment of COVID-19
The Table below was published in e-book International Pulmonologist’s Consensus On Covid-19 2nd ed 2020 on April 22nd 2020 (ed. Tinku
Gilead to Test a Version of Remdesivir That Can Be Inhaled
The New York Times published on June 22, 2020: The American biopharmaceutical company Gilead Sciences will soon start trials of
A cheap and widely available steroid, dexamethasone can help save the lives of patients seriously ill with coronavirus
Researchers led by Professor Peter Horby at the University of Oxford, in England say they have the first evidence that